Suppr超能文献

肺动脉高压合并心肺共病患者死亡率的超声心动图预测指标

Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities.

作者信息

Steiner Johannes, Wu Wen-Chih, Jankowich Matthew, Maron Bradley A, Sharma Satish, Choudhary Gaurav

机构信息

Vascular Research Laboratory, Providence VA Medical Center, Providence, Rhode Island, United States of America; Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.

Veterans Affairs Boston Healthcare System, Department of Cardiology, Boston, Massachusetts, United States of America; Brigham and Women's Hospital and Harvard Medical School, Department of Internal Medicine, Division of Cardiovascular Medicine, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2015 Mar 16;10(3):e0119277. doi: 10.1371/journal.pone.0119277. eCollection 2015.

Abstract

OBJECTIVE

We aimed to identify the echocardiographic measures associated with survival in a patient population with a high prevalence of co-morbid cardiovascular and pulmonary disease that have significantly elevated estimated pulmonary artery systolic pressures (ePASP).

BACKGROUND

Pulmonary hypertension (PH) is a clinical feature of several cardiopulmonary diseases that are prevalent among elderly. While certain echocardiographic parameters have been shown to be important in the prognosis in specific PH groups, the prognostic relevance of echocardiographic characteristics in a cohort with multiple cardiopulmonary comorbidities is unclear.

METHODS

We retrospectively identified 152 patients with ePASP > 60 mmHg by echocardiography over a five year period (6/2006-11/2011) and followed until 4/2013. Candidate clinical and echocardiographic characteristics suggestive of PH severity were compared between deceased and surviving subpopulations. Cox proportional hazard modeling was used to identify echocardiographic predictors of death adjusted for age and clinical characteristics.

RESULTS

This was a predominantly elderly (age 78.8 ± 10.2 years), male (98.7%) cohort with several cardiopulmonary comorbidities. Overall mortality was high (69.7%, median survival 129 days). After adjusting for age and clinical characteristics, decreased right ventricular (RV) systolic function assessed by tricuspid annular plane systolic excursion (HR 0.56, 95% CI 0.33-0.96, p = 0.034) and increased RV thickness (HR: 4.34, 95% CI: 1.49-12.59, p = 0.007) were independently associated with mortality. In contrast, left ventricular systolic function, left ventricular diastolic parameters, ePASP, or echo-derived pulmonary vascular resistance (PVR) were not associated with increased mortality.

CONCLUSION

In a cohort of patients with PH and high prevalence of cardio-pulmonary comorbidities, RV systolic function and hypertrophy are associated with mortality and may be the most relevant echocardiographic markers for prognosis.

摘要

目的

我们旨在确定在合并心血管和肺部疾病患病率高且估计肺动脉收缩压(ePASP)显著升高的患者群体中,与生存相关的超声心动图测量指标。

背景

肺动脉高压(PH)是几种心肺疾病的临床特征,在老年人中很常见。虽然某些超声心动图参数已被证明在特定PH组的预后中很重要,但超声心动图特征在具有多种心肺合并症的队列中的预后相关性尚不清楚。

方法

我们回顾性地通过超声心动图在五年期间(2006年6月至2011年11月)确定了152例ePASP>60 mmHg的患者,并随访至2013年4月。比较死亡亚组和存活亚组之间提示PH严重程度的候选临床和超声心动图特征。使用Cox比例风险模型确定经年龄和临床特征调整后的死亡超声心动图预测因子。

结果

这是一个主要为老年人(年龄78.8±10.2岁)、男性(98.7%)的队列,有多种心肺合并症。总体死亡率很高(69.7%,中位生存期129天)。在调整年龄和临床特征后,通过三尖瓣环平面收缩期位移评估的右心室(RV)收缩功能降低(HR 0.56,95%CI 0.33 - 0.96,p = 0.034)和RV厚度增加(HR:4.34,95%CI:1.49 - 12.59,p = 0.007)与死亡率独立相关。相比之下,左心室收缩功能、左心室舒张参数、ePASP或超声心动图衍生的肺血管阻力(PVR)与死亡率增加无关。

结论

在一组PH患者且心肺合并症患病率高的队列中,RV收缩功能和肥厚与死亡率相关,可能是最相关的超声心动图预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd44/4361665/1fc87be2e9fd/pone.0119277.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验